NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that it...

Oral presentation highlights the first time it's been demonstrated that the DOR is expressed on tumor-associated MDSCs, and that DOR inhibition reprograms multiple mechanisms of MDSC- induced...

Sanitation Strategies, LLC will publicly debut its solid acid Perpetual Drum™ System at the upcoming National AALAS Annual Meeting in Long Beach, California, November 10–13, 2025 (Booth #628)....

New data from Phase 1/2 study of enzomenib (DSP-5336) in patients with relapsed/refractory acute myeloid leukemia (AML) show promising clinical activity across a wide range of potentially...

Today, the U.S. Green Building Council (USGBC), the global developer of the LEED (Leadership in Energy and Environmental Design) standards, opened certification to the LEED v5 rating system and...